Evidence map›Paper›PMID 36678752›Full record

ArticlePharmaceutics2022

Fabrication, Optimization, and Characterization of Antibacterial Electrospun Shellac Fibers Loaded with

Wantanwa Krongrawa, Sontaya Limmatvapirat, Mont Kumpugdee Vollrath, Prasat Kittakoop, Supachai Saibua, Chutima Limmatvapirat

Abstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Fabrication and evaluation of ribavirin-loaded electrospun nanofibers as an antimicrobial wound dressing.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  3. Article
  4. Response to Article "International journal of nanomedicine · 2024
    Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wantanwa KrongrawaDepartment of Industrial Pharmacy, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000, Thailand.
Sontaya LimmatvapiratDepartment of Industrial Pharmacy, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000, Thailand.ORCID 0000-0002-3829-4062
Mont Kumpugdee VollrathLaboratory Pharmaceutical Technology, Faculty II-Mathematics-Physics-Chemistry, Berliner Hochschule für Technik, Luxemburger Str.10, 13353 Berlin, Germany.
Prasat KittakoopChulabhorn Graduate Institute, Program in Chemical Sciences, Chulabhorn Royal Academy, Bangkok 10210, Thailand.ORCID 0000-0002-5210-3162
Supachai SaibuaBangkok Lab & Cosmetic Co., Ltd., 48/1, Moo 5, Nongsaesao Road, Tambon Namphu, Amphoe Muang Ratchaburi, Ratchaburi 70000, Thailand.
Chutima LimmatvapiratDepartment of Industrial Pharmacy, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000, Thailand.ORCID 0000-0002-7378-7065

Funding

The Industrial Division of the Thailand Research Fund (TRF) RDG6150102
6 · The paper itself

Abstract

This study aimed to develop a

Indexed as

antibacterial activityBox–Behnken designdissolutionelectrospun fiberKaempferia parvifloramethoxyflavonesshellac

Identifiers

PMID36678752
PMCPMC9861391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.